On Nov 2, 2021 Shoreline Biosciences closed a Venture – Series Unknown round and raised $140,000,000 from Ally Bridge Group, BeiGene, Boxer Capital, BVF Partners, Commodore Capital, Cormorant Asset Management, Eventide Asset Management, Irving Investors, Janus Henderson Investors, Kingdon Capital, Kite Pharma, NS Investment, Piper Sandler, Stork Capital S.à.r.l., Superstring Capital, Wedbush Securities, featuring lead investors Ally Bridge Group.

About the company: Shoreline Biosciences is located at United States, North America.
“”

Company website: http://www.shorelinebio.com